Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.

Helena PlaMarta PardoÀngel J IzquierdoEsther DarderAnna CarbóElisabet MuntéSara Torres-EsquiusJudith BalmañaConcepción LázaroJoan M BrunetMaria-Pilar Barretina-Ginesta

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

In our cohort, the risk of EC in BRCA1/2 carriers after RRSO is not greater than expected. Hysterectomy is not routinely recommended for these patients.

Keyphrases

endometrial cancer
end stage renal disease
ejection fraction
chronic kidney disease
clinical trial
peritoneal dialysis
prognostic factors
study protocol
patient reported outcomes
cross sectional
breast cancer risk